Bausch + Lomb Co. (NYSE:BLCO) Receives Consensus Rating of “Hold” from Analysts

Shares of Bausch + Lomb Co. (NYSE:BLCO) have been assigned a consensus rating of “Hold” from the thirteen brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $20.25.

A number of equities analysts have commented on the stock. Wells Fargo & Company cut their price objective on shares of Bausch + Lomb from $26.00 to $24.00 and set an “overweight” rating on the stock in a report on Thursday, January 16th. Stifel Nicolaus cut their target price on shares of Bausch + Lomb from $19.00 to $18.00 and set a “hold” rating on the stock in a research note on Wednesday, January 29th. Royal Bank of Canada lowered their price objective on shares of Bausch + Lomb from $23.00 to $22.00 and set an “outperform” rating for the company in a research report on Wednesday, January 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of Bausch + Lomb in a research report on Thursday, October 31st. Finally, Bank of America restated an “underperform” rating and issued a $18.00 target price on shares of Bausch + Lomb in a research report on Thursday, December 12th.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of BLCO. Barclays PLC acquired a new position in Bausch + Lomb in the 3rd quarter valued at $5,797,000. Quadrature Capital Ltd acquired a new stake in Bausch + Lomb in the 3rd quarter valued at about $526,000. River Road Asset Management LLC increased its position in Bausch + Lomb by 4.4% in the 3rd quarter. River Road Asset Management LLC now owns 2,020,414 shares of the company’s stock valued at $38,974,000 after acquiring an additional 85,987 shares in the last quarter. Janus Henderson Group PLC acquired a new stake in shares of Bausch + Lomb during the 3rd quarter worth approximately $957,000. Finally, Cubist Systematic Strategies LLC acquired a new stake in shares of Bausch + Lomb during the 2nd quarter worth approximately $580,000. Institutional investors and hedge funds own 11.07% of the company’s stock.

Bausch + Lomb Stock Performance

NYSE:BLCO opened at $17.45 on Thursday. The company has a current ratio of 1.57, a quick ratio of 0.95 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $6.15 billion, a price-to-earnings ratio of -16.61, a PEG ratio of 2.30 and a beta of 0.46. The firm’s fifty day simple moving average is $18.25 and its 200 day simple moving average is $18.16. Bausch + Lomb has a twelve month low of $13.16 and a twelve month high of $21.69.

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.